Ureteral Stent Length and Patient Symptoms
This study has been terminated.
(Because no staff to consent or enroll subjects)
Information provided by (Responsible Party):
John G Pattaras, MD, Emory University
First received: February 6, 2006
Last updated: December 23, 2013
Last verified: December 2013
The Study of whether or not Ureteral Stent Length affects patient comfort after electro-shock wave treatment for kidney stones.
Device: Ureteral Stent
||Time Perspective: Prospective
| Study Start Date:
| Study Completion Date:
Device: Ureteral Stent
Ureteral stents are not investigatory but rather part of standard of care. In this study, we were interested in having patients fill out pre and post-operative questionnaires so that we could compare their symptoms with the length of their ureter and the stent placed.
Patients undergoing electro shock wave for treatment of kidney stones are randomized to long or short stent length after signing an informed consent prior to their surgery. They keep a pain diary and medication diary for a two week period after the stent is placed. These are turned in at the two week post-op visit. Patients also complete a quality of life and urinary symptom score questionnaire pre and post operatively.
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Male or female over 18 years of age, will be receiving electro-shock wave therapy for kidney stones
Inclusion Criteria: Male or female over 18 years of age, will be receiving electro-shock wave therapy for kidney stones -
Exclusion Criteria:Under 18 years of age, inability to give informed consent
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00288457
||John G Pattaras, MD
No publications provided
||John G Pattaras, MD, Associate Professor, Emory University
History of Changes
|Other Study ID Numbers:
|Study First Received:
||February 6, 2006
||December 23, 2013
||United States: Food and Drug Administration
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on November 20, 2014
Pathological Conditions, Anatomical